Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

These following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:


    September 30, 2022 (Unaudited)       September 30, 2021 (Unaudited)  
Options to purchase common stock     1,835,452       -  
Warrants to purchase common stock     2,337,274       2,337,274  
Unvested restricted common stock     295,588       -  
Convertible Series C Preferred Stock      -         7   
Total anti-dilutive securities      4,468,314         2,337,281